Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Charles & Colvard, Ltd. (CTHR:NASDAQ), powered by AI.
Charles & Colvard, Ltd. is currently trading at $0.10. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Charles & Colvard, Ltd. on Alpha Lenz.
Charles & Colvard, Ltd.'s P/E ratio is -0.0.
“Charles & Colvard, Ltd. trades at a P/E of -0.0 (undervalued) with modest ROE of -43.9%.”
Ask for details →Charles & Colvard, Ltd. is a renowned purveyor of ethically sourced lab-created gemstones, specifically known for its moissanite jewelry. The company's primary function is to produce and market these synthetic gemstones, offering a sustainable and cost-effective alternative to traditional mined diamonds. Charles & Colvard's moissanite products span a variety of jewelry types, including engagement rings, earrings, and pendants, appealing to an environmentally conscious consumer base. Headquartered in North Carolina, Charles & Colvard positions itself at the intersection of technology and luxury, striving for appeal in both retail jewelry and wholesale markets. Their innovative approach not only challenges conventional jewelry standards but also promotes ethical treatment of natural resources. As a publicly traded company, Charles & Colvard plays a vital role in the jewelry sector, contributing to the growing market of lab-grown gemstones, a segment increasingly relevant in discussions around sustainability and ethical manufacturing practices. The company's commitment to quality and sustainability makes it a significant player in redefining the luxury experience for today’s conscious consumers.
“Charles & Colvard, Ltd. trades at a P/E of -0.0 (undervalued) with modest ROE of -43.9%.”
Ask for details →Charles & Colvard, Ltd. (ticker: CTHR) is a company listed on NASDAQ in the Consumer Cyclical sector (Luxury Goods). It has approximately 24 employees. Market cap is $303,450.
The current price is $0.1 with a P/E ratio of -0.02x and P/B of 0.01x.
ROE is -43.91% and operating margin is -59.81%. Annual revenue is $22M.